Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have been diagnosed with rheumatoid arthritis (RA) based on recognized medical guidelines
- For one part of the study (Sub-study 1): Your standard first-line arthritis medications have not worked well enough, and your doctor considers you ready to try a more advanced type of medication
- For another part of the study (Sub-study 2): At least one specific type of advanced arthritis medication (called a TNF inhibitor) has not worked well enough for you, and your doctor considers you ready to try a different advanced medication
Who may not be able to join:
- For Sub-study 1: You have already used advanced biologic or targeted arthritis medications before; for Sub-study 2: You have used advanced arthritis medications other than TNF inhibitors before
- You have a condition that makes it unsafe to take advanced arthritis medications, such as an active infection, untreated latent tuberculosis (TB), current cancer, serious organ problems, a history of blood clots (unless you are on blood thinners), high cardiovascular risk, or if you are pregnant or breastfeeding
- You have another inflammatory condition alongside your arthritis that requires its own specific immune-suppressing treatment (for example, a form of lupus affecting the kidneys)
- You are unable to give your consent or fill out study forms in English or French, even with help from someone else
⚠️ Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marie Hudson, MD, Sir Mortimer B. Davis - Jewish General Hospital
Phone: 514-340-8222
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Rate of recruitment at two RA referral centers over 12 months; Prompt access to drugs; Proportion of participants adhering to the allocated treatment; Proportion of eligible patients who are invited to participate by their physician; Proportion of eligible patients who accept to participate; Proportion of patients reaching SDAI <= 3.3; Proportion of patients reaching DAS28 LDA state; Patient-reported outcomes (function, health-related quality of life, fatigue)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.